SIGMATRON INTERNATIONAL INC (SGMA) Fundamental Analysis & Valuation

NASDAQ:SGMA • US82661L1017

Current stock price

3.01 USD
-0.01 (-0.33%)
At close:
3.01 USD
0 (0%)
After Hours:

This SGMA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SGMA Profitability Analysis

1.1 Basic Checks

  • SGMA had negative earnings in the past year.
  • SGMA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SGMA reported negative net income in multiple years.
  • In multiple years SGMA reported negative operating cash flow during the last 5 years.
SGMA Yearly Net Income VS EBIT VS OCF VS FCFSGMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

  • With a Return On Assets value of -6.35%, SGMA is not doing good in the industry: 60.80% of the companies in the same industry are doing better.
  • With a Return On Equity value of -21.28%, SGMA is not doing good in the industry: 66.40% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.35%
ROE -21.28%
ROIC N/A
ROA(3y)-1.8%
ROA(5y)-0.88%
ROE(3y)-7.6%
ROE(5y)-3.93%
ROIC(3y)N/A
ROIC(5y)N/A
SGMA Yearly ROA, ROE, ROICSGMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • SGMA's Operating Margin has improved in the last couple of years.
  • SGMA has a Gross Margin of 7.42%. This is amonst the worse of the industry: SGMA underperforms 84.00% of its industry peers.
  • SGMA's Gross Margin has been stable in the last couple of years.
  • SGMA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.42%
OM growth 3Y15.94%
OM growth 5Y12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y-0.18%
SGMA Yearly Profit, Operating, Gross MarginsSGMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SGMA Health Analysis

2.1 Basic Checks

  • SGMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SGMA has been increased compared to 1 year ago.
  • The number of shares outstanding for SGMA has been increased compared to 5 years ago.
  • Compared to 1 year ago, SGMA has an improved debt to assets ratio.
SGMA Yearly Shares OutstandingSGMA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
SGMA Yearly Total Debt VS Total AssetsSGMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 1.93 indicates that SGMA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.93, SGMA is doing worse than 69.60% of the companies in the same industry.
  • The Debt to FCF ratio of SGMA is 2.38, which is a good value as it means it would take SGMA, 2.38 years of fcf income to pay off all of its debts.
  • SGMA's Debt to FCF ratio of 2.38 is fine compared to the rest of the industry. SGMA outperforms 73.60% of its industry peers.
  • SGMA has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
  • SGMA has a Debt to Equity ratio (0.07) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 2.38
Altman-Z 1.93
ROIC/WACCN/A
WACC10.81%
SGMA Yearly LT Debt VS Equity VS FCFSGMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that SGMA should not have too much problems paying its short term obligations.
  • SGMA's Current ratio of 1.23 is on the low side compared to the rest of the industry. SGMA is outperformed by 87.20% of its industry peers.
  • A Quick Ratio of 0.35 indicates that SGMA may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.35, SGMA is doing worse than 96.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.35
SGMA Yearly Current Assets VS Current LiabilitesSGMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SGMA Growth Analysis

3.1 Past

  • SGMA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1202.52%.
  • SGMA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.02%.
  • SGMA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.17% yearly.
EPS 1Y (TTM)-1202.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%539.22%
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y10.42%
Revenue growth 5Y5.17%
Sales Q2Q%-25.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGMA Yearly Revenue VS EstimatesSGMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

Find the best growth stocksShow best growing peers

2

4. SGMA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SGMA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGMA Price Earnings VS Forward Price EarningsSGMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • SGMA's Enterprise Value to EBITDA is on the same level as the industry average.
  • 100.00% of the companies in the same industry are more expensive than SGMA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.78
EV/EBITDA 20.29
SGMA Per share dataSGMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SGMA Dividend Analysis

5.1 Amount

  • SGMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SGMA Fundamentals: All Metrics, Ratios and Statistics

SIGMATRON INTERNATIONAL INC

NASDAQ:SGMA (7/25/2025, 8:25:03 PM)

After market: 3.01 0 (0%)

3.01

-0.01 (-0.33%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-06
Earnings (Next)09-01
Inst Owners37.75%
Inst Owner ChangeN/A
Ins Owners18.85%
Ins Owner Change0%
Market Cap18.42M
Revenue(TTM)311.71M
Net Income(TTM)-12.25M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF 0.78
P/OCF 0.75
P/B 0.32
P/tB 0.32
EV/EBITDA 20.29
EPS(TTM)-2.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.85
FCFY127.99%
OCF(TTM)4.03
OCFY133.74%
SpS50.93
BVpS9.4
TBVpS9.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.35%
ROE -21.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.42%
FCFM 7.56%
ROA(3y)-1.8%
ROA(5y)-0.88%
ROE(3y)-7.6%
ROE(5y)-3.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.02%
ROCE(5y)9.57%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y15.94%
OM growth 5Y12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y-0.18%
F-Score3
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 2.38
Debt/EBITDA 1.14
Cap/Depr 17.46%
Cap/Sales 0.34%
Interest Coverage N/A
Cash Conversion 690.28%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.35
Altman-Z 1.93
F-Score3
WACC10.81%
ROIC/WACCN/A
Cap/Depr(3y)59.02%
Cap/Depr(5y)70.3%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1202.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%539.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y10.42%
Revenue growth 5Y5.17%
Sales Q2Q%-25.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-109.88%
EBIT growth 3Y28.02%
EBIT growth 5Y18.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y150.38%
FCF growth 3Y97.89%
FCF growth 5YN/A
OCF growth 1Y153.86%
OCF growth 3Y50.77%
OCF growth 5YN/A

SIGMATRON INTERNATIONAL INC / SGMA Fundamental Analysis FAQ

What is the fundamental rating for SGMA stock?

ChartMill assigns a fundamental rating of 2 / 10 to SGMA.


What is the valuation status of SIGMATRON INTERNATIONAL INC (SGMA) stock?

ChartMill assigns a valuation rating of 2 / 10 to SIGMATRON INTERNATIONAL INC (SGMA). This can be considered as Overvalued.


Can you provide the profitability details for SIGMATRON INTERNATIONAL INC?

SIGMATRON INTERNATIONAL INC (SGMA) has a profitability rating of 2 / 10.


What is the financial health of SIGMATRON INTERNATIONAL INC (SGMA) stock?

The financial health rating of SIGMATRON INTERNATIONAL INC (SGMA) is 3 / 10.